Peer-reviewed scientific papers authored by the Neiman Institute investigators, fellows, and affiliates.
In this cohort study of 794,809 commercially insured men from 2011 to 2017 undergoing a prostate-specific antigen test, Black and Hispanic patients were significantly less likely than White patients to undergo
prostate magnetic resonance imaging after receiving an elevated test score. Full Article
Nino Abashidze, PhD, Chad Stecher, PhD, Andrew B. Rosenkrantz, MD, MPA, Richard Duszak Jr, MD, Danny R. Hughes, PhD. 2021. "Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test," JAMA Network Open
A series of policy briefs and research columns focusing on topical issues in imaging health policy.
April 21, 2022
Consumer price listings may ultimately give consumers less of what they really want — high quality care. While transparent pricing is theoretically ideal for allowing patients to make informed decisions, the complexity of healthcare in the U.S. makes a truly transparent system a challenge and there are numerous caveats. Read the JACR Bulletin Column
Infographics produced primarily with Neiman Almanac data to better understand current health care issues.
January 11, 2021
The Radiology Support, Communication and Alignment Network (R-SCAN) is a quality improvement program through which patients, referring clinicians, and radiologists collaborate to improve imaging appropriateness based on Choosing Wisely recommendations and ACR Appropriateness Criteria. In the current study, we aimed to estimate the potential imaging cost savings associated with R-SCAN use for the Medicare population. View Infographic
